- Filed
- Feb 10, 2025 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q2 2025 · Feb 3, 2025 | 47.01M sh |
| Cash And Equivalents | Q2 2025 · Dec 31, 2024 | $19.91M |
| Cash And Equivalents | Q2 2025 · Jun 30, 2024 | $24.87M |
| Cash And Equivalents | Q2 2025 · Dec 31, 2023 | $32.88M |
| Stockholders Equity | Q2 2025 · Dec 31, 2024 | $214.45M |
| Stockholders Equity | Q2 2025 · Jun 30, 2024 | $209.36M |
| Current Liabilities | Q2 2025 · Dec 31, 2024 | $108.1M |
| Current Liabilities | Q2 2025 · Jun 30, 2024 | $110.45M |
| Total Liabilities | Q2 2025 · Dec 31, 2024 | $172.21M |
| Total Liabilities | Q2 2025 · Jun 30, 2024 | $161.68M |
| Current Assets | Q2 2025 · Dec 31, 2024 | $152.87M |
| Current Assets | Q2 2025 · Jun 30, 2024 | $164.21M |
| Total Assets | Q2 2025 · Dec 31, 2024 | $386.76M |
| Total Assets | Q2 2025 · Jun 30, 2024 | $371.19M |
| Total Assets | Q2 2025 · Dec 31, 2023 | $363.04M |
| Shares Diluted | Q2 2025 · Dec 31, 2023 | 48.91M sh |
| Shares Diluted | Q2 2025 · Dec 31, 2023 | 48.99M sh |
| Stock Repurchased | Q2 2025 · Dec 31, 2023 | $3.08M |
| Capex | Q2 2025 · Dec 31, 2023 | $5.02M |
| Operating Cash Flow | Q2 2025 · Dec 31, 2023 | $12.09M |
| Eps Diluted | Q2 2025 · Dec 31, 2023 | $0.02 |
| Eps Diluted | Q2 2025 · Dec 31, 2023 | $0.07 |
| Eps Basic | Q2 2025 · Dec 31, 2023 | $0.02 |
| Eps Basic | Q2 2025 · Dec 31, 2023 | $0.08 |
| Sga Expense restated | Q2 2025 · Dec 31, 2023 | $10.52M |
| Sga Expense restated | Q2 2025 · Dec 31, 2023 | $19.99M |
| Net Income | Q2 2025 · Dec 31, 2023 | $985K |
| Net Income | Q2 2025 · Dec 31, 2023 | $3.61M |
| Operating Income | Q2 2025 · Dec 31, 2023 | $1.66M |
| Operating Income | Q2 2025 · Dec 31, 2023 | $5.33M |
| Revenue | Q2 2025 · Dec 31, 2023 | $201.08M |
| Revenue | Q2 2025 · Dec 31, 2023 | $411.88M |